Sex is a powerful modulator of disease susceptibility, course and outcome. The gene CACNA1C is among the best replicated vulnerability genes of bipolar disorder and schizophrenia. The aim of the present study was to investigate whether sex and a variant in CACNA1C (rs10774035 as a proxy for the well-acknowledged risk variant rs1006737) influence psychosocial adaptation in a large German patient sample with schizophrenia-spectrum (n= 297) and bipolar (n =516) disorders. We analyzed Global Assessment of Functioning (GAF) scores, retrospectively collected for different time points during disease course. We investigated whether CACNA1C sex-dependently modulates longitudinal GAF scores and recovery from episodes of psychiatric disturbance in the above mentioned disorders. Psychosocial recovery was measured as difference score between the current GAF score (assessing the last remission) and the worst GAF score ever during an illness episode. Covariate-adjusted association analyses revealed a sex Â rs10774035 genotype interaction on longitudinal GAF and recovery from illness episodes only in schizophrenia-spectrum but not in bipolar disorders. In schizophrenia-spectrum affected males, rs10774035 minor allele (T) carriers had higher GAF scores at three time points (premorbid, worst ever, current). In contrast, females carrying rs10774035 minor alleles had impaired recovery from schizophrenia-spectrum episodes. These results encourage further investigations of gene Â sex interactions and longitudinal quantitative phenotypes to unravel the rich variety of behavioral consequences of genetic individuality.
A common risk variant in CACNA1C supports a sex-dependent effect on longitudinal functioning and functional recovery from episodes of schizophrenia-spectrum but not bipolar disorder Acute episodes of schizophrenia-spectrum (SZspec) and bipolar disorders (BDs) are characterized by a steep decline in overall psychosocial functioning. Both disorders can have a chronic course characterized by recurring episodes of intense behavioral symptoms. There is, however, great inter-individual variation in the severity of impairment over time, ranging from a single mild episode to chronic impairment without recovery between episodes. Disease severity can be assessed comprehensively by quantifying overall psychosocial functioning on a single global continuum provided by the Global Assessment of Functioning (GAF) scale (DSM-IV Axis V). This approach allows for comparison between disorders and is also more sensitive to changes over time than symptom-specific assessments (Endicott et al., 1976) . Changes in psychosocial functioning over time can be used as a measure of outcome or functional recovery from episodes of mental disorders (Jobe and Harrow, 2005; Lieberman et al., 2008) .
The sex-specific genetic architecture of mental disorders has gained attention lately (Ober et al., 2008) , sparked by a finding in the Reelin gene that increases the risk to develop SZspec in females but not males (Shifman et al., 2008) . Subsequent investigation by Goes et al. (2009) also implicated Reelin as a sex-specific genetic risk factor in BDs, pointing to a sex-specific cross-disorder vulnerability locus. Similarly, evidence for sex-specific effects of CACNA1C has recently been established (Strohmaier et al., 2013) . CAC-NA1C, coding for an L-type voltage-gated calcium channel subunit, is among the most intensively studied genes involved in the etiology of both BDs and SZspec (Bhat et al., 2012; Green et al., 2010) . Whereas CACNA1C as susceptibility locus for SZspec and BDs has been identified hypothesis-free by case-control genome-wide association studies (GWAS) its full behavioral consequences have yet to be elucidated. Therefore, the present study probes the modulating role of CACNA1C variants on longitudinal outcome within SZspec and BD patients on a continuous measure of disease course within cases. We took advantage of a large German sample (n = 813) with measures on the degree of psychosocial adaptation at different disease stages. Given that there are well-known sex-specific differences in the course of both SZspec (Gur et al., 1996; Leung and Chue, 2000) and BDs (Azorin et al., 2013; Hendrick et al., 2000; Kawa et al., 2005; Kessing, 2004) , we hypothesized sex to exert a modulating influence on the putative effects of CACNA1C on longitudinal course of global functioning levels and on recovery from episodes of psychiatric disturbance. Specifically, we investigated the sexdependent association between psychosocial adaptation, including recovery from illness episodes, and the CACNA1C single nucleotide polymorphism (SNP) rs10774035. In European populations, this SNP is in strong linkage disequilibrium (LD) with SNP rs1006737 (r 2 =1.000 and D 0 = 1.000, SNAP database http://www.broadinstitute.org/mpg/snap/ ), for which genetic associations with SZspec and BDs have been shown. In line with other studies (e.g. Bigos et al., 2010) , we thus investigated the effects of CACNA1C rs1006737 via a proxy SNP.
in accordance with the Declaration of Helsinki. Informed written consent was obtained prior to study participation from all participants.
CACNA1C polymorphism
The C/T (minor allele) polymorphism rs10774035 is in strong LD with the G/A (minor allele) polymorphism rs1006737 for European populations (SNAP database; http://www.broad institute.org/mpg/snap/, r 2 =1.000, D 0 = 1.000) and was directly genotyped fulfilling standard quality control criteria (Rietschel et al., 2012) . Both SNPs are located in an intron of the CACNA1C gene. (http://www.ncbi.nlm.nih.gov/pro jects/SNP/snp_ref.cgi?rs =10774035). Observed minor allele frequencies (MAFs) for rs10774035 were similar in both diagnostic groups and sexes, with overlapping 95% confi dence intervals indicating no differences at the 5% signifi cance level (see Table 1 ). In addition to the strong LD with rs1006737, the genotyped variant rs10774035 is located in a DNAse I hypersensitive region, according to RegulomeDB (http://regulomedb.org/snp/chr12/2368673).
DNAse I hypersensitivity indicates a remodeled chromatin state related to transcriptional activity, as these have lost their condensed structure and are therefore accessible to regula tory proteins, e.g. transcription factors.
Phenotypes
For each subject, we analyzed longitudinal GAF scores (DSM-IV Axis V), retrospectively collected for different time points during illness course (see below), as principal dependent variable. Historically, the GAF scale was developed from the Global Assessment Scale (GAS) which assesses general psychosocial functioning on a health-illness continuum ranging from 1 to 100 (Endicott et al., 1976) . Briefly, GAS values of 100-91 correspond to superior psychosocial functioning, whereas values of 10-1 are used to describe the low end of this continuum in which an individual needs constant supervision to avoid damage to itself or others or to ensure minimal personal hygiene. The GAS was initially developed by Luborsky (1962) as Health-Sickness Rating Scale, revised by Endicott et al. (1976) under the name GAS of which a modified version was included in the DSM-III-R (Cooper and Michels, 1988) and, with minimal changes, also in the DSM-VI as GAF scale (Axis V). GAF information was assessed for three time points during the individual disease course: GAF1: the premorbid GAF, defined as the highest GAF score present before illness onset GAF2: the worst GAF score ever, i.e. the lowest GAF value ever present during an illness episode GAF3: the current GAF (pre-admission GAF) defined as the GAF score right before the "current" episode for which the patient received clinical treatment at the time of interview All assessments were performed by board-certified psychiatrists or psychologists or psychiatry/psychology trainees at advanced stages in their postgraduate education. GAF1 and GAF2 were retrospectively assessed based on a multitude of sources to increase the validity of this retrospective assessment, including a structured diagnostic interview with the patient, a thorough examination of clinical records, and family interview method, whenever possible, The difference score of GAF3 and GAF2 ("current status" (last remission) minus "worst ever") served as a measure for the degree of recovery from episodes of psychiatric disorder. We analyzed all participants for whom information on rs10774035 genotype, age, duration of illness and GAF scores were complete. 
Statistical analyses
We used the software R (version 3.0.2, www.r-project.org). All p-values reported are two-sided. BD and SZspec samples were analyzed separately as well-known sex-specific differences in the course of SZspec and BD may yield different interaction patterns with sex. GAF values covary with sex and age at illness onset (premorbid GAF) or with sex and duration of illness (worst ever and current GAF, see Gade et al. (2015) . We therefore adjusted GAF scores by linear regression for age at illness onset or duration of illness, separately for females and males. The GAF linear regression residuals at all three time points were jointly analyzed by non-parametric longitudinal rank-sum test LNPT (Malzahn et al., 2010 ; R package nparLD: Noguchi et al., 2012) . The LNPT statistic resembles a hetero scedastic, two-way repeated measures ANOVA with two-level factor sex and three-level factor CACNA1C rs10774035 geno type. When a significant sex Â genotype interaction was found, subsequent analyses tested rs10774035 main effects separately in males and females. Sex-stratified analyses also considered the recovery phenotype (GAF3 minus GAF2). Latter was adjusted for sex, duration of illness, and premorbid GAF (as recovery correlates with premorbid levels of psychosocial adaptation, data not shown). When analyzing recovery in males and females, we took advantage of a non-parametric maximum test (Marcus, 1982) that accounts for the unknown genetic mode of inheritance R package nparcomp) . Note that LNPT and nparcomp are both robust against potential variance heterogeneity between genotype groups or time points and remain valid and powerful also for non-normally distributed target variables. Table 1 displays descriptive statistics of and statistical comparisons between both diagnostic samples. Clinically expected differences are a lower percentage of females in SZspec compared to BDs, earlier age of onset of SZspec in males but not in females compared to BDs, and consistently lower GAF scores throughout all three time points as well as worse recovery in SZspec compared to BDs for men and women.
Results
Patients with BDs had a longer duration of illness at the time of observation compared to the SZspec patients. All other statistical test results are covariate-adjusted (including adjustment for sex, age at illness onset, duration of illness) and displayed in Table 2 (as well as in Figures 1 and 2 ).
Longitudinal analysis of covariate-adjusted residual GAF scores
LNPT detected no sex Â CACNA1C interaction in the BD sample (p= 0.870). In contrast, sex Â CACNA1C interaction was significant in the SZspec sample (p= 0.012, see Table 2 ). Figure 1 illustrates that the CACNA1C rs10774035 minor (T) allele had a beneficial main effect on longitudinal residual GAF scores in SZspec affected males (p= 0.018).
In SZspec affected males, the rs10774035 TT genotype was associated with elevated median residual GAF scores at all three time points, compared to the CC and CT genotype groups. In contrast, SZspec affected females displayed an opposing -but non-significant -tendency towards reduced premorbid and current median residual GAF scores in female T allele carriers (LNPT on residual GAF1, 3: p= 0.125). However, residual GAF2 scores behaved differently (LNPT on residual GAF1, 2, 3: p =0.482, i.e. greatly increased p-value when including residual GAF2).
CACNA1C rs10774035 effects on covariateadjusted residual recovery from illness episodes
As reported above, CACNA1C rs10774035 genotype affected residual GAF scores in SZspec males consistently at all three time points. Correspondingly, residuals of the recovery phenotype were not significantly affected by rs10774035 in SZspec males (p= 0.966). In contrast, the rs10774035 minor (T) allele significantly reduced residuals of the recovery phenotype in SZ spec females (p =0.042) consistent with a dominant mode of inheritance (see Figure 2) . The associations of CACNA1C rs10774035 with outcome in SZspec and non-association with outcome in BDs were also found when additionally adjusting GAF scores for diagnostic subcategory and when only analyzing the largest diagnostic subgroups (schizophrenia, bipolar I disorder), respectively (data not shown).
Discussion
We investigated sex-dependent effects of CACNA1C rs10774035 genotype, a proxy SNP for the widely studied a Longitudinal rank-sum test LNPT (average rs10774035 effects on GAF over all three time points): joint analysis of covariate-adjusted linear regression residuals of premorbid, worst ever, and current GAF scores. Latter were adjusted for age at illness onset (premorbid GAF) or duration of illness (worst ever GAF, current GAF), separately for females and males.
b Non-longitudinal rank-sum test nparcomp on covariateadjusted residual recovery in males or females. Residual recovery is the regression residual obtained on the difference score between current GAF minus worst ever GAF. This difference score was adjusted for duration of illness and premorbid GAF, separately for females and males.
CACNA1C risk variant rs1006737, in SZspec and BDs. We used GAF scores as dependent variables, investigating the course of psychosocial adaptation with a special emphasis on recovery from illness episodes. In the following, we discuss results of the present study in light of the effects of CACNA1C in case-control and population-based studies. For reasons of clarity, we refer to the T allele of rs10774035 (proxy SNP investigated in the present study) and the A allele of rs1006737 collectively as CACNA1C minor allele. Across sexes, it is well known that polymorphisms in the CACNA1C gene confer susceptibility to SZspec and BD (Cross-Disorder Group of the Psychiatric Genomics Consortium, Genetic Risk Outcome of Psychosis (G. R. O. U. P) Consortium; Dao et al., 2010; Ferreira et al., 2008; Green et al., 2010; Hamshere et al., 2013; Liu et al., 2011; Moskvina et al., 2009; Nyegaard et al., 2010; Sklar et al., 2011 Sklar et al., , 2008 Wray et al., 2012) . However, the investigation of sex-specific genetic effects underlying disease risk has shown that the genetic basis for many diseases differs in males and females (Goes et al., 2009; Liu et al., 2012; Ober et al., 2008; Shifman et al., 2008) . Such differential effect in females and males have been shown for CACNA1C (Dao et al., 2010; Strohmaier et al., 2013; Witt et al., 2014) and an association in one sex may drive the association in a sample in which sexes are pooled. Given CACNA1C's role in the etiology of both SZspec and BDs, we hypothesized longitudinal course of these disorders to be differentially affected between sexes. Our analyses of GAF levels for three time points in the disease course revealed evidence for sex-specific effects only in the SZspec sample. In line with the view of schizophrenia being a neurodevelopmental disorder (Murray and Lewis, 1987; Woods, 1998) this may be indicative of an early interplay between the sex-specific regulatory genome (Ober et al., 2008) , a polymorphic CACNA1C gene and pathophysiology in ontogeny. In SZspec affected males, the CACNA1C minor allele had a main effect on the level of longitudinal GAF regardless of time point investigated, with the homozygous genotype having a beneficial effect (see Figure 1) . Our finding may thus be considered out of line with results in the population-based study of Strohmaier et al. (2013) , where, in males, the minor allele was associated with lower resilience phenotypes. In the present study, recovery in SZspec affected males was not influenced by CACNA1C genotype. In marked contrast, CACNA1C rs10774035 genotype influenced longitudinal course, particularly functional recovery from episodes, in SZspec affected females. Here, the CACNA1C minor allele was found to have a detrimental effect, consistent with a dominant model of inheritance. However, in females, Strohmaier et al. (2013) found the CACNA1C minor allele to be associated with resilience phenotypes in the general population and thus again in contrast to the present study. These conflicting results of our study and that of Strohmaier et al. (2013) may be explained by acknowledging the fact that different phenotypes were investigated in different study samples and that the mechanisms underlying these phenotypes may play a unique role in health and disease. Alternatively, these results may be an example of the so-called flip-flop phenomenon (Lin et al., 2007) , pointing to the explanation that the CACNA1C locus is correlated with a causal variant. The CACNA1C gene codes for the pore-forming alpha1C subunit of the voltagedependent L-type calcium channel (Ca V 1.2) (Bhat et al., 2012) . Sequence variation in intronic regions of the gene, such as the polymorphisms investigated herein, are thought to influence not functional channel properties but rather expression levels and RNA splicing. In support of this, Bigos et al. (2010) have found greater CACNA1C expression in carriers of the minor allele. Importantly, calcium ions themselves play a crucial role in regulating gene expression (e.g. West et al., 2001 ). An explanation of the seemingly incongruent role of rs1006737/rs10774035 in psychiatric disease may thus stem from the fact that CACNA1C is a major regulator of downstream processes itself via the regulation of intracellular calcium concentration.
Besides rs1006737, CACNA1C rs1024582 and rs2007044 have recently been implicated as putative pathogenic loci by GWAS (Cross-Disorder Group of the Psychiatric Genomics Consortium, Genetic Risk Outcome of Psychosis (G. R. O. U. P) Consortium; Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014). Both loci are in high LD with rs1006737 (rs1024582: r 2 =0.933, D 0 = 1.000; rs2007044: r 2 = 0.788, D 0 = 1.000). Data on rs2007044 were available for our sample and associated similarly but slightly weaker (data not shown) compared to the rs1006737 proxy rs10774035.
Overall, our results suggest that molecular genetic studies using longitudinal and/or sex-specific analyses of quantitative traits underlying mental disorders have the potential to unravel complex genetic interactions. To our knowledge, this is also the first study that relates a genetic polymorphism to improvement following episodes of psychiatric disease. However, the above mentioned differences compared to the study of Strohmaier et al. (2013) emphasize the need for an independent replication.
We used the GAF scale to assess the course of psychosocial adaptation. This instrument is an easy-to-use method that needs relatively little information (Dworkin et al., 1990; Endicott et al., 1976) . It correlates well with both symptom ratings (Skodol et al., 1988) and psychosocial variables (Startup et al., 2002) . Moreover, the GAF scale has been shown to be a sensitive instrument in multiplerater longitudinal studies (Dworkin et al., 1990) .
Our approach mimics a longitudinal design. While we consider this to be a particular strength of our study, the retrospective measurement of GAF values (psychosocial adaptation) is certainly a limitation. Although earlier studies caution against the use of retrospective assessment when investigating psychosocial variables (Henry et al., 1994) , it should be emphasized that, in the present study, raters maximized reliability by integrating information from different sources (patient interview, medical records, Figure 2 CACNA1C rs10774035 affects recovery from SZspec episodes. Upper row: covariate-adjusted residual recovery from episodes of SZ-spectrum disorders, stratified by sex and CACNA1C rs10774035 genotype. Lower row: nonparametric test for dominant, additive and recessive modes of inheritance of the CACNA1C rs10774035 minor (T) allele. Significant results do not include the dotted line at value 0.5. relatives) and did not solely rely on the recollection of study participants.
A further limitation of the present study is also the lack of systematically collected information on medication. Psychotropic medication is known to influence GAF ratings (Jones et al., 1995) , and medication adherence is an important predictor of disease outcome (e.g. AscherSvanum et al., 2006; Verdoux et al., 2000) . However, the lack of sex-specific differences in medication adherence (Lacro et al., 2002) argues against confounding of the sexgenotype interactions studied herein.
Finally, the sample size, while not large in comparison with studies on diagnostic categories, is the largest to date for studying genetics of longitudinal global functioning in SZspec and BDs. Our study underscores the need for studies investigating the complex interplay between sex and confirmed risk variants on longitudinal disease characteristics.
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